Oncology

News

ASCO: Moderna may file melanoma vaccine on phase 2b data

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme

News

ASCO: DREAMM-8 data puts GSK’s Blenrep back on track

GSK is increasingly confident that its anti-BCMA drug Blenrep could be returned to the US market, after revealing data from the DREAMM-8 trial of the drug in multiple myel

News

ASCO: AstraZeneca’s triple whammy in lung and breast cancer

Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ASCO congress.

News

ASCO: Conversational AI tackles missed colonoscopies

An artificial intelligence-based tool has shown impressive results in raising colorectal cancer screening rates in underserved populations.

News

ASCO: Novartis’ Scemblix aces first-line CML study

Novartis’ first-in-class STAMP inhibitor Scemblix could be headed for use earlier in the treatment pathway for chronic myeloid leukaemia (CML).

News

Gilead’s Trodelvy woes rise with failed bladder cancer trial

Gilead Sciences' TROP2-directed drug Trodelvy has missed the target in another clinical trial, this time in urothelial carcinoma, the most common form of bladder cancer.

ASCO: Moderna may file melanoma vaccine on phase 2b data

ASCO: DREAMM-8 data puts GSK’s Blenrep back on track

ASCO: AstraZeneca’s triple whammy in lung and breast cancer

ASCO: Conversational AI tackles missed colonoscopies

ASCO: Novartis’ Scemblix aces first-line CML study

Gilead’s Trodelvy woes rise with failed bladder cancer trial

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Oncology

Editor's Picks